148 related articles for article (PubMed ID: 6410450)
1. Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788.
Darragh A; Lambe R; O'Boyle C; Kenny M; Brick I
Psychopharmacology (Berl); 1983; 80(2):192-5. PubMed ID: 6410450
[TBL] [Abstract][Full Text] [Related]
2. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364.
Saletu B; Grünberger J; Cepko H
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):421-37. PubMed ID: 2888736
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of the central effects of 3-methylclonazepam.
Darragh A; Lambe R; Brick I; O'Boyle C
Br J Clin Pharmacol; 1982 Dec; 14(6):871-2. PubMed ID: 6817773
[No Abstract] [Full Text] [Related]
4. The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.
Higgitt A; Lader M; Fonagy P
Psychopharmacology (Berl); 1986; 89(4):395-403. PubMed ID: 3092269
[TBL] [Abstract][Full Text] [Related]
5. Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil.
Curran HV; Birch B
Psychopharmacology (Berl); 1991; 103(4):519-23. PubMed ID: 1676530
[TBL] [Abstract][Full Text] [Related]
6. RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.
Darragh A; Lambe R; Kenny M; Brick I; Taaffe W; O'Boyle C
Br J Clin Pharmacol; 1982 Nov; 14(5):677-82. PubMed ID: 6814472
[TBL] [Abstract][Full Text] [Related]
7. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of adenosine accumulation by a CNS benzodiazepine antagonist (Ro 15-1788) and a peripheral benzodiazepine receptor ligand (Ro 05-4864).
Morgan PF; Lloyd HG; Stone TW
Neurosci Lett; 1983 Oct; 41(1-2):183-8. PubMed ID: 6417576
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation.
Schöpf J; Laurian S; Le PK; Gaillard JM
Pharmacopsychiatry; 1984 May; 17(3):79-83. PubMed ID: 6429677
[TBL] [Abstract][Full Text] [Related]
10. Central effects in man of the novel schistosomicidal benzodiazepine meclonazepam.
O'Boyle C; Lambe R; Darragh A
Eur J Clin Pharmacol; 1985; 29(1):105-8. PubMed ID: 4054198
[TBL] [Abstract][Full Text] [Related]
11. Anxiogenic and non-anxiogenic benzodiazepine antagonists.
Prado de Carvalho LP; Grecksch G; Chapouthier G; Rossier J
Nature; 1983 Jan; 301(5895):64-6. PubMed ID: 6296684
[TBL] [Abstract][Full Text] [Related]
12. Stimulus control induced by benzodiazepine antagonist Ro 15-1788 in the rat.
De Vry J; Slangen JL
Psychopharmacology (Berl); 1985; 85(4):483-5. PubMed ID: 3927344
[TBL] [Abstract][Full Text] [Related]
13. Behavioural actions of Ro 5-4864: a peripheral-type benzodiazepine?
Pellow S; File SE
Life Sci; 1984 Jul; 35(3):229-40. PubMed ID: 6087055
[TBL] [Abstract][Full Text] [Related]
14. Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.
Gentil V; Tavares S; Gorenstein C; Bello C; Mathias L; Gronich G; Singer J
Psychopharmacology (Berl); 1990; 100(1):54-9. PubMed ID: 2104987
[TBL] [Abstract][Full Text] [Related]
15. Effects of lorazepam on memory, attention and sedation in man: antagonism by Ro 15-1788.
Preston GC; Ward CE; Broks P; Traub M; Stahl SM
Psychopharmacology (Berl); 1989; 97(2):222-7. PubMed ID: 2498931
[TBL] [Abstract][Full Text] [Related]
16. Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability.
O'Boyle C; Lambe R; Darragh A; Taffe W; Brick I; Kenny M
Br J Anaesth; 1983 Apr; 55(4):349-56. PubMed ID: 6404290
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the benzodiazepine antagonists, CGS 8216 and Ro 15-1788, with central adenosine A-1 receptors.
Williams M; Risley EA
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):50-3. PubMed ID: 6299218
[TBL] [Abstract][Full Text] [Related]
18. Anticonflict action of sodium valproate. Interaction with convulsant benzodiazepine (Ro 5-3663) and imidazodiazepine (Ro 15-1788).
Myslobodsky M; Feldon J; Lerner T
Life Sci; 1983 Jul; 33(4):317-21. PubMed ID: 6135965
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.
File SE; Dingemanse J; Friedman HL; Greenblatt DJ
Psychopharmacology (Berl); 1986; 89(1):113-7. PubMed ID: 3090585
[TBL] [Abstract][Full Text] [Related]
20. Using Ro 15-1788 to investigate the benzodiazepine receptor in vivo: studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663.
Green AR; Nutt DJ; Cowen PJ
Psychopharmacology (Berl); 1982; 78(3):293-5. PubMed ID: 6296905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
